相关实验视频
Updated: Jan 14, 2026
06:17
Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
22.7K
开发一种交叉保护的普通感冒冠状病毒疫苗
Tanushree Dangi1, Shiyi Li2, Pablo Penaloza-MacMaster1,2
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Journal of virology
|October 22, 2025
概括
一种针对OC43冠状病毒尖端蛋白的新型mRNA疫苗显示出有希望. 这种疫苗不仅可以保护小鼠免受OC43的感染,还可以对其他胚胎病毒 (如MHV-A59) 进行交叉保护.
科学领域:
- * 病毒学 病毒学
- * 免疫学 免疫学
- * 疫苗开发工作
背景情况:
- *普通感冒冠状病毒 (例如,OC43,HKU1) 在健康个体中引起轻度疾病,但在高风险群体中引起严重疾病.
- * 目前对于普通感冒冠状病毒没有经过临床批准的疫苗.
- *易受伤害的群体,包括免疫力低下的个体和老年人,面临重大风险.
研究的目的:
- *开发和评估一种针对OC43冠状病毒的mRNA疫苗.
- * 评估疫苗在预防同源和异源冠状病毒挑战方面的有效性.
- * 探索对抗胚胎病毒的广泛保护的潜力.
主要方法:
- *开发一种编码来自OC43冠状病毒稳定尖端蛋白的mRNA疫苗.
- * 在C57BL/6小鼠模型中测试疫苗的疗效.
- *对免疫反应的评估,包括特异性和交叉反应性抗体和细胞免疫.
- *使用OC43和小鼠肝炎病毒 (MHV-A59) 的挑战性研究.
主要成果:
- *OC43 mRNA疫苗成功引起了OC43特定的免疫反应.
- * 疫苗诱导了对其他胚胎病毒的交叉反应性免疫力,包括HKU1和MHV-A59.
- * 接种疫苗的小鼠证明了对致命的OC43感染的保护,并与遥远的恩贝科病毒MHV-A59.9进行了挑战.
结论:
- * 一种针对OC43尖端蛋白的mRNA疫苗可以提供对同源和异源胚胎病毒感染的保护.
- * 这种方法证明了开发单一疫苗的可行性,以广泛保护embbecovirus亚系内的多种冠状病毒.
- *研究结果支持全面冠状病毒疫苗战略的发展.
相关概念视频
00:42Cross-reactivity
32.8K
Overview
32.8K
01:22Development of Immunocompetence
789
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
789
01:51Vaccinations
51.2K
Overview
51.2K
01:29Immune Response Against Viral Pathogens
1.7K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.7K